Related Experiment Video

Updated: May 9, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Salinomycin: a novel anti-cancer agent with known anti-coccidial activities

Shuang Zhou1, Fengfei Wang, Eric T Wong

  • 1Department of Pharmaceutical Sciences, North Dakota State University, 203 Sudro Hall, NDSU Dept 2665, PO Box 6050, Fargo, ND 58108-6050. erxi.wu@ndsu.edu.

Current Medicinal Chemistry
|August 13, 2013
PubMed

Insights

Salinomycin, an anti-coccidial drug, shows promise as a novel anti-cancer agent by targeting cancer stem cells (CSCs) and overcoming drug resistance. Further research is needed to understand its mechanisms and potential limitations.

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Discovery

Background:

  • Salinomycin is an established anti-coccidial drug.
  • Emerging evidence suggests salinomycin exhibits anti-cancer and anti-cancer stem cell (CSC) properties.
  • It also demonstrates potential in overcoming multi-drug resistance in cancer.

Purpose of the Study:

  • To review the pharmacological effects of salinomycin.
  • To explore potential mechanisms of its anti-tumorigenic activities.
  • To discuss recent advances and limitations for its clinical application.

Main Methods:

  • Literature review of studies involving human cancer cell lines.
  • Analysis of data from xenograft mouse models.
  • Examination of case reports from pilot clinical trials in cancer patients.

Main Results:

  • Salinomycin demonstrates significant anti-cancer and anti-CSC effects.
  • It shows efficacy in overcoming multi-drug resistance.
  • Pilot clinical trials suggest potential therapeutic benefits.

Conclusions:

  • Salinomycin is a promising candidate for novel cancer therapy.
  • Understanding its mechanism of action is crucial for optimizing its use.
  • Potential complications require careful consideration for clinical utilization.

More Related Videos

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...